Because IDO1 activity is closely related to Trp levels, the activation of IDO1 and the involvement of the immune system and inflammation in depression suggest that the inhibition of IDO1 could be a target for discovering antidepressant drugs (Romani et al., 2008; Huang et al., 2020). Here, IDO1 is linked to depressive symptom measurement.